Vanda Pharmaceuticals Inc (VNDA)
4.935
+0.04
(+0.71%)
USD |
NASDAQ |
Nov 21, 16:00
4.935
0.00 (0.00%)
After-Hours: 17:37
Vanda Pharmaceuticals Price: 4.935 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 4.90 | 4.92 | 4.82 | 4.90 | 396102.0 |
| Nov 19, 2024 | 4.93 | 4.96 | 4.84 | 4.92 | 434817.0 |
| Nov 18, 2024 | 5.00 | 5.07 | 4.86 | 4.98 | 610103.0 |
| Nov 15, 2024 | 5.12 | 5.12 | 4.955 | 5.00 | 668295.0 |
| Nov 14, 2024 | 5.47 | 5.497 | 5.07 | 5.10 | 835458.0 |
| Nov 13, 2024 | 5.47 | 5.525 | 5.37 | 5.46 | 747842.0 |
| Nov 12, 2024 | 5.35 | 5.545 | 5.265 | 5.40 | 991378.0 |
| Nov 11, 2024 | 5.25 | 5.415 | 5.165 | 5.34 | 1.251M |
| Nov 08, 2024 | 5.04 | 5.230 | 5.02 | 5.19 | 831245.0 |
| Nov 07, 2024 | 4.80 | 5.295 | 4.80 | 5.02 | 1.111M |
| Nov 06, 2024 | 4.79 | 4.905 | 4.715 | 4.89 | 909850.0 |
| Nov 05, 2024 | 4.80 | 4.80 | 4.66 | 4.79 | 597952.0 |
| Nov 04, 2024 | 4.66 | 4.885 | 4.65 | 4.85 | 783082.0 |
| Nov 01, 2024 | 4.66 | 4.71 | 4.62 | 4.66 | 397341.0 |
| Oct 31, 2024 | 4.75 | 4.77 | 4.615 | 4.65 | 469063.0 |
| Oct 30, 2024 | 4.62 | 4.705 | 4.56 | 4.56 | 319465.0 |
| Oct 29, 2024 | 4.75 | 4.80 | 4.62 | 4.69 | 262058.0 |
| Oct 28, 2024 | 4.59 | 4.79 | 4.59 | 4.78 | 337930.0 |
| Oct 25, 2024 | 4.55 | 4.60 | 4.47 | 4.55 | 445761.0 |
| Oct 24, 2024 | 4.65 | 4.69 | 4.495 | 4.52 | 471071.0 |
| Oct 23, 2024 | 4.67 | 4.72 | 4.625 | 4.69 | 335123.0 |
| Oct 22, 2024 | 4.74 | 4.820 | 4.705 | 4.73 | 311143.0 |
| Oct 21, 2024 | 4.93 | 4.93 | 4.73 | 4.73 | 389148.0 |
| Oct 18, 2024 | 4.73 | 4.93 | 4.675 | 4.91 | 650424.0 |
| Oct 17, 2024 | 4.90 | 4.90 | 4.715 | 4.735 | 396028.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.38
Minimum
Nov 09 2023
21.51
Maximum
Jun 30 2021
10.34
Average
10.38
Median
Aug 23 2022
Price Benchmarks
| Zevra Therapeutics Inc | 9.145 |
| Black Diamond Therapeutics Inc | 2.435 |
| Edgewise Therapeutics Inc | 32.01 |
| NovaBay Pharmaceuticals Inc | 0.718 |
| Palatin Technologies Inc | 0.91 |
Price Related Metrics
| PS Ratio | 1.499 |
| Price to Book Value | 0.5317 |
| Earnings Yield | -5.67% |
| Market Cap | 287.75M |